Open-angle glaucoma

Related records

Broader conditions (7)

• Disease
• Disease by body system or component
• Disorder of orbital region
• Disorder of visual system
• Eye disorder
• Glaucoma
• Human disease

Narrower conditions (13)

• Glaucoma 1, open angle, A
• Glaucoma 1, open angle, J
• Glaucoma 1, open angle, K
• Glaucoma 1, open angle, l
• Glaucoma 1, open angle, M
• Glaucoma 1, open angle, N
• Glaucoma 1, open angle, O
• Glaucoma 1, open angle, P
• Glaucoma type 1C
• Juvenile open angle glaucoma
• Low tension glaucoma
• OPTN-related open angle glaucoma
• Residual stage of open angle glaucoma

Trials (917)

• [KJ-TFC-005] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
• 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA)
• 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
• 24 Hour IOP Lowering Efficacy of AL-3789
• 24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
• 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.
• 24-hour Efficacy of AR-12286
• 24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients
• 24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination
• 24-hour IOP-lowering Effect of Brimonidine 0.1%
• 24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations
• 24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
• 24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed Combination
• 24h Continuous Intraocular Pressure (IOP) Monitoring vs Goldmann Applanation Tonometry
• 5-Year Postoperative Outcomes of Patients Who Completed the CREST Study
• A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma
• A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
• A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma
• A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma
• A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma

Approved drugs (17)

• Betaxolol hydrochloride
• Bimatoprost
• Brimonidine tartrate
• Brinzolamide
• Carteolol hydrochloride
• Dapiprazole hydrochloride
• Dorzolamide hydrochloride
• Latanoprost
• Latanoprostene bunod
• Methazolamide
• Netarsudil dimesylate
• Omidenepag isopropyl
• Pilocarpine
• Tafluprost
• Timolol
• Timolol maleate
• Travoprost

Drugs in development (21)

• Anecortave acetate Phase 2
• Betaxolol Phase 3
• Bimatoprost grenod Phase 2
• Brimonidine Phase 2
• Citicoline Phase 3
• DE-104 Phase 2
• Dorzolamide Phase 3
• Evodenoson Phase 1
• Fluorouracil Phase 3
• Ginkgo Phase 2
• Memantine Phase 3
• Mitomycin Phase 2
• Netarsudil Early phase 1
• Niacinamide Phase 2
• Ofloxacin Phase 3
• Prednisolone Phase 3
• Pyruvate Phase 2
• Ranibizumab Phase 1
• Sodium chloride Phase 2
• Trabodenoson Phase 3

Other linked drugs (4)

• Demecarium bromide
• Levobunolol
• Metformin
• Metipranolol